WealthPKNews

WealthPK News

Image for: From manufacturing to innovation: What China's pharmaceutical shift means for Pakistan

From manufacturing to innovation: What China's pharmaceutical shift means for Pakistan

ISLAMABAD, Oct 23 (INP-Wealth Pakistan) -- China's biotechnology sector is expanding its role in the global pharmaceutical industry, moving beyond the manufacturing of conventional medicines and pharmaceutical ingredients to the development and international licensing of innovative drugs, as growing demand for Chinese-developed therapies creates new opportunities for international research and commercial partnerships.

WealthPK Reports

WealthPK Reports

Data News

Image for: HBL posts 9M’26 profit before tax of Rs 115 billion, while creating sustainable value for its clients and stakeholders

HBL posts 9M’26 profit before tax of Rs 115 billion, while creating sustainable value for its clients and stakeholders

HBL today declared a record quarterly profit before tax of Rs 41.9 billion for the third quarter of 2026. The Bank’s total profit before tax for nine months ended September 30, 2026, increased to Rs 115 billion while the profit after tax rose to Rs 54.1 billion. EPS for 9M’26 increased to Rs 36.84. Along with the results, the Bank declared an interim cash dividend for the third quarter ended September 30, 2026, at Rs 6.0 per share. This is in addition to the interim cash dividend already paid at Rs 12 per share i.e. 120%.

HBL